HSIC vs SOLV · P/E 24, rev $12.67B vs P/E 9.1, rev $8.25B
Henry Schein Inc (HSIC) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the HSIC and SOLV stock pages for the full models.
Not investment advice.